Metabolism and distribution of fibrinogen. II. Fibrinogen turnover in polycythaemia, thrombocytosis, haemophilia A, congenital afibrinogenaemia and during streptokinase therapy.
D000328:Adult; D000347:Afibrinogenemia / Q000151:congenital / Q000378:metabolism*; D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology; D000933:Antifibrinolytic Agents / Q000494:pharmacology; D004211:Disseminated Intravascular Coagulation / Q000378:metabolism; D005260:Female; D005340:Fibrinogen / Q000378:metabolism*; D005342:Fibrinolysis / Q000187:drug effects; D006207:Half-Life; D006467:Hemophilia A / Q000378:metabolism*; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000378:metabolism*; D013300:Streptokinase / Q000627:therapeutic use*; D013922:Thrombocytosis / Q000378:metabolism*
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D005340:Fibrinogen; D006493:Heparin; D013300:Streptokinase